In a House Oversight subcommittee hearing on Feb. 26, the Inflation Reduction Act (IRA) was hit with the usual swipes from detractors, with some calling it the “green scam”, but China’s solar company benefits were never mentioned.
In 2024, China and India accounted for 57.6% of total U.S. pharmaceutical imports by weight, highlighting the potential risks associated with such reliance. Growing U.S. dependence on China and India for widely-used generic pharmaceutical products creates serious risks to national security and patient safety when drugs are in short supply, or ineffective.
President Trump’s executive order sends a clear message: The days of allowing China to weaponize US investment and financial markets against us are over.
CPA announced key leadership changes as CEO Michael Stumo steps down to take on a new role in the Trump administration. Jon Toomey has been elevated as President of CPA to lead the organization and Nick Iacovella has been promoted to Executive Vice President.
Industrial Policy for the United States seeks to list all of the tools a country can use to improve its industrial base and entice businesses to invest in manufacturing. If these tools are deployed, the authors argue, the results will be good for local economies and labor.
The duties impact several major Chinese solar brands, including Jinko Solar and Trina Solar, as well as Vietnamese manufacturers that Commerce believes have been circumventing tariffs by importing components from mainland China for final assembly.
For far too long, America has been at the mercy of foreign producers that routinely violate FDA safety regulations for life-saving medicines, generic drugs, and essential medical equipment.
It’s the most well-known secret on Capitol Hill: China owns the American generic drug supply chain. Basic thyroid or blood pressure medications might finally be put into pill form in an Indian lab and sold under an Indian brand like Cipla. But the organic compounds, or key starting materials, mostly come from China.
China is forecast to account for 45% of the world’s global industrial production by 2030. That growth comes at the expense of the West, which is projected to drop to 11% of global production in the next five years.
This long-overdue action will protect American manufacturers and workers from the devastating surge of foreign imports that has harmed U.S. industry, particularly from Mexico in blatant violation of the 2019 Joint Steel and Aluminum Agreement.
